Who is sponsoring NCT04144660?

NCT04144660 is sponsored by Sarah Thordsen.

What drugs are being tested in NCT04144660?

Interventions in NCT04144660: Extracorporeal Membrane Oxygenation.

What condition does NCT04144660 study?

NCT04144660 studies Cardiogenic Shock, Peripartum Cardiomyopathy, Complication, Pregnancy.

Is NCT04144660 still recruiting?

NCT04144660 is currently completed. Last updated 23 November 2020.

Last reviewed 2020-11-23 · How we verify

NCT04144660

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

"Treatment Use of ECMO In Pregnancy or Peripartum Patient."

Completed Last updated 23 November 2020

What this trial tests

trial testing Extracorporeal Membrane Oxygenation in Cardiogenic Shock in 5 participants. Completed in 31 March 2020.

Timeline

28 October 2019

Primary endpoint
31 March 2020

31 March 2020

Quick facts

Lead sponsor	Sarah Thordsen
Status	Completed
Study type	OBSERVATIONAL
Enrollment	5
Start date	28 October 2019
Primary completion	31 March 2020
Estimated completion	31 March 2020
Sites	1 location across United States

Drugs / interventions tested

Extracorporeal Membrane Oxygenation

Conditions studied

Cardiogenic Shock — all drugs for Cardiogenic Shock →
Peripartum Cardiomyopathy — all drugs for Peripartum Cardiomyopathy →
Complication, Pregnancy — all drugs for Complication, Pregnancy →

Sponsor

Sarah Thordsen

Who can join

18 and older, female only, with Cardiogenic Shock or Peripartum Cardiomyopathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to describe the use of ECMO (Extracorporeal Membrane Oxygenation) in the pregnant or peripartum patient.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Extracorporeal Membrane Oxygenation

Trials testing the same drug.

NCT05387902 — Short-term Outcomes of Elective High-risk PCI With Extracorporeal Membrane Oxygenation Support: a Single-centre Registry · completed
NCT03021538 — Bypass vs. Ecmo in Lung Transplantation (BELT) · terminated
NCT03979222 — Observational Cohort Study of a National Extracorporeal Membrane Oxygenation Service for Adults With Respiratory Failure · completed

Other recruiting trials for Cardiogenic Shock

Currently open trials in the same condition.

NCT07527156 — Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure · Phase 4 · recruiting
NCT07345559 — Personalisation of Mean Arterial Pressure in Adult Patients With Cardiogenic Shock · NA · recruiting
NCT07374289 — On Scene ECPR in Ostrava · NA · recruiting
NCT07402018 — Intra-aortic Balloon Counterpulsation (IABC) Compliance · recruiting
NCT07309029 — Pre-Emptive LAVA-ECMO for Complex High-Risk TAVR · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04144660 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sarah Thordsen
Last refreshed: 23 November 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04144660.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing